August 24, 2015

IDEAS study to explore amyloid PET and Alzheimer's

Over the next five to six years, researchers, clinicians, patients, and a host of nonprofit organizations from across the U.S. will collaborate to tackle a few of the nation’s most vexing and complex health issues via the Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) study of Alzheimer’s disease, dementia, and cognitive impairment.  The $100 million, groundbreaking IDEAS study will, among a series of goals, evaluate the clinical utility of amyloid PET imaging to diagnose these debilitating conditions, according to Dr. Gil Rabinovici, an assistant professor of neurology at the University of California, San Francisco (UCSF) Memory and Aging Center. {read more here}